Acute respiratory disease (ARD) due to adenoviruses caused significant
morbidity in military training populations, Since 1971 ARD has been c
ontrolled by the use of live, enteric-coated, adenovirus (ADV) types 4
and 7 vaccines, This immunization program overcame significant proble
ms in vaccine development, Due to a production delay, military trainin
g posts stopped ADV vaccine administration in spring 1994, The deliver
y of ADV vaccine resumed in late February 1995, but another production
delay is anticipated, A generation of military medical people have no
t been exposed to the significant morbidity caused by adenoviruses and
are unaware of the effectiveness of the ADV vaccine. ARD morbidity be
fore ADV vaccines, the ADV Vaccine development program, and current is
sues regarding the control of ARD due to adenoviruses in the military
are discussed.